This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n19http://localhost/temp/predkladatel/
n13http://linked.opendata.cz/resource/domain/vavai/projekt/
n4http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n12http://linked.opendata.cz/resource/domain/vavai/subjekt/
n11http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n20http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n18http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11160%2F11%3A10100467%21RIV12-GA0-11160___/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n21http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n14http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11160%2F11%3A10100467%21RIV12-GA0-11160___
rdf:type
n11:Vysledek skos:Concept
rdfs:seeAlso
http://informahealthcare.com/doi/pdf/10.3109/03602532.2011.609174
dcterms:description
A searching for some possibilities how to increase DOX efficacy in cancer cells and minimizing associated toxicities to non-cancerous tissues is in the forefront of scientific research. This review brings an overview of various approaches and a summary of their principles. Possible advantages, disadvantages and further perspectives are discussed and evaluated. A searching for some possibilities how to increase DOX efficacy in cancer cells and minimizing associated toxicities to non-cancerous tissues is in the forefront of scientific research. This review brings an overview of various approaches and a summary of their principles. Possible advantages, disadvantages and further perspectives are discussed and evaluated.
dcterms:title
Possibilities to increase the effectiveness of doxorubicin in cancer cells killing Possibilities to increase the effectiveness of doxorubicin in cancer cells killing
skos:prefLabel
Possibilities to increase the effectiveness of doxorubicin in cancer cells killing Possibilities to increase the effectiveness of doxorubicin in cancer cells killing
skos:notation
RIV/00216208:11160/11:10100467!RIV12-GA0-11160___
n11:predkladatel
n12:orjk%3A11160
n3:aktivita
n15:S n15:P
n3:aktivity
P(GP524/09/P121), S
n3:cisloPeriodika
4
n3:dodaniDat
n14:2012
n3:domaciTvurceVysledku
n4:1405764 n4:2270455 n4:8996563
n3:druhVysledku
n17:J
n3:duvernostUdaju
n9:S
n3:entitaPredkladatele
n18:predkladatel
n3:idSjednocenehoVysledku
221793
n3:idVysledku
RIV/00216208:11160/11:10100467
n3:jazykVysledku
n21:eng
n3:klicovaSlova
oxidative stress; doxorubicin deactivation; resistance; efflux transporters; doxorubicin conjugation
n3:klicoveSlovo
n8:efflux%20transporters n8:resistance n8:doxorubicin%20conjugation n8:doxorubicin%20deactivation n8:oxidative%20stress
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[28DF5E4FFDFF]
n3:nazevZdroje
Drug Metabolism Reviews
n3:obor
n7:FR
n3:pocetDomacichTvurcuVysledku
3
n3:pocetTvurcuVysledku
3
n3:projekt
n13:GP524%2F09%2FP121
n3:rokUplatneniVysledku
n14:2011
n3:svazekPeriodika
43
n3:tvurceVysledku
Boušová, Iva Skálová, Lenka Hanušová, Veronika
n3:wos
000296092500007
s:issn
0360-2532
s:numberOfPages
18
n20:doi
10.3109/03602532.2011.609174
n19:organizacniJednotka
11160